Why the study?
What are the hemodynamic effects of pargyline in hypertensive patients?
What are the hemodynamic effects of pargyline in hypertensive patients?
Pargyline lowers blood pressure primarily by reducing peripheral vascular resistance, but requires caution in patients with renal impairment due to its reduction of glomerular filtration rate.
Answers are grounded in this paper and cite their sources.
May require renal monitoring in hypertensives; leaves open its role versus modern agents.
Pargyline exerts its antihypertensive effect via a predominant reduction in peripheral vascular resistance, whereas cardiac output is not altered significantly. The effect on renal blood flow is inconsistent, but a significant reduction in glomerular filtration rate does occur. Therefore the drug should be used with appropriate caution in patients with significant impairment of renal function. The hemodynamic response observed with pargyline is similar to that obtained with other MAO inhibitors.
No takes yet. Share an insight, caveat, or question.
Onesti et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: